Nurse Practitioner, Family · Jacksonville, FL
NPI
1235212549
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2 Shircliff Way Ste 900
Jacksonville, FL, 32204
Phone (904) 381-9651
Groups this clinician bills Medicare through
Medicare paid, 2023
$4,382
133 services
Medicare patients, 2023
47
Average age 60
Drug cost, 2024
$13.3M
8,579 prescriptions
Company payments, 2025
$1,109
From 5 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Sharon D Reiley was code 36415 (venipuncture blood collection), 69 times for 36 patients. In total Sharon D Reiley billed 133 services in 10 codes, and Medicare paid $4,382.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 69 | 36 | $8.40 | $580 |
| 99214 Office E&M - Established | Office | 46 | 37 | $64.12 | $2,949 |
By year: 2022 $9,639 for 353 services; 2023 $4,382 for 133 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 69 | 36 | $8.40 | $580 |
Medicare prescription drug claims, 2024
In 2024, the drug Sharon D Reiley prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 1,223 prescriptions and refills. In total Sharon D Reiley wrote 8,579 Medicare prescriptions that cost $13.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 1,223 | 1,225 | 135 | $4.8M |
| Tivicay Dolutegravir Sodium | 706 | 714 | 82 | $1.7M |
| Prezcobix Darunavir/Cobicistat | 441 | 441 | 50 | $1.1M |
| Atorvastatin Calcium Generic | 433 | 506 | 62 | $1,560 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 419 | 419 | 47 | $1.6M |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 248 | 248 | 28 | $1.1M |
| Amlodipine Besylate Generic | 245 | 265 | 36 | $702 |
| Rosuvastatin Calcium Generic | 227 | 266 | 36 | $732 |
| Juluca Dolutegravir/Rilpivirine | 214 | 214 | 21 | $745K |
| Gabapentin Generic | 207 | 211 | 32 | $1,990 |
| Lisinopril Generic | 183 | 226 | 37 | $773 |
| Hydrochlorothiazide Generic | 168 | 175 | 21 | $514 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 163 | 163 | 18 | $590K |
| Jardiance Empagliflozin | 154 | 165 | 21 | $99K |
| Fenofibrate Fenofibrate Nanocrystallized | 150 | 172 | 27 | $1,690 |
Brand drugs: 4,439 claims; generic drugs: 4,113 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharon D Reiley $1,109 ($1,109 in general payments such as food, travel and fees) from 5 companies. The largest payer was Gilead Sciences, Inc. with $394.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.